[go: up one dir, main page]

UA39884C2 - Таблетка на основі клодронової кислоти, спосіб її одержання та спосіб лікування остеопорозу - Google Patents

Таблетка на основі клодронової кислоти, спосіб її одержання та спосіб лікування остеопорозу

Info

Publication number
UA39884C2
UA39884C2 UA95114854A UA95114854A UA39884C2 UA 39884 C2 UA39884 C2 UA 39884C2 UA 95114854 A UA95114854 A UA 95114854A UA 95114854 A UA95114854 A UA 95114854A UA 39884 C2 UA39884 C2 UA 39884C2
Authority
UA
Ukraine
Prior art keywords
production
osteoporosis
treatment
drug
clodronic acid
Prior art date
Application number
UA95114854A
Other languages
English (en)
Inventor
Вальтер Прайс
Бернд Мюзель
Гюнтер НОЙГЕБАУЕР
Рольф-Дітер Габель
Original Assignee
Рош Діагностікс, Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25927331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA39884(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9307393U external-priority patent/DE9307393U1/de
Priority claimed from DE19934322057 external-priority patent/DE4322057A1/de
Application filed by Рош Діагностікс, Гмбх filed Critical Рош Діагностікс, Гмбх
Publication of UA39884C2 publication Critical patent/UA39884C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Препарат "ФЛАВОСОРБ" і способ його одержання відноситься до біотехнології. Винахід може бути використано у фармацевтичній промисловості і медицині. Новим у винаході є створення препарату с детоксикуючою та антиоксидантною активністю. Спосіб одержання препарату полягає в іммобілізації біологічно активної речовини – кверцетину у вигляді 0,04 % спиртового розчину на активованому вуглецевому волокнистому матеріалі.
UA95114854A 1993-05-15 1993-07-24 Таблетка на основі клодронової кислоти, спосіб її одержання та спосіб лікування остеопорозу UA39884C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (de) 1993-05-15 1993-05-15 Tablette mit verbesserter Bioverfügbarkeit, enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DE19934322057 DE4322057A1 (de) 1993-07-02 1993-07-02 Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
PCT/EP1993/001967 WO1994026310A1 (de) 1993-05-15 1993-07-24 Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff

Publications (1)

Publication Number Publication Date
UA39884C2 true UA39884C2 (uk) 2001-07-16

Family

ID=25927331

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95114854A UA39884C2 (uk) 1993-05-15 1993-07-24 Таблетка на основі клодронової кислоти, спосіб її одержання та спосіб лікування остеопорозу

Country Status (25)

Country Link
US (1) US5650168A (uk)
EP (2) EP0697890A1 (uk)
JP (1) JP3699110B2 (uk)
KR (1) KR100263284B1 (uk)
CN (1) CN1041797C (uk)
AT (2) ATE128363T1 (uk)
AU (1) AU687744B2 (uk)
BR (1) BR9307859A (uk)
CA (1) CA2162470C (uk)
CZ (1) CZ287984B6 (uk)
DE (1) DE59300688D1 (uk)
DK (1) DK0625355T5 (uk)
ES (1) ES2065313T5 (uk)
FI (1) FI111519B (uk)
GR (2) GR940300095T1 (uk)
HU (1) HU220872B1 (uk)
IL (1) IL106743A (uk)
NO (1) NO307548B1 (uk)
NZ (1) NZ254765A (uk)
PL (1) PL173026B1 (uk)
RU (1) RU2134103C1 (uk)
SK (1) SK281193B6 (uk)
TW (1) TW350772B (uk)
UA (1) UA39884C2 (uk)
WO (1) WO1994026310A1 (uk)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
CZ20002567A3 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
EA013106B1 (ru) * 2003-09-19 2010-02-26 Сан Фарма Адвансед Ресьорч Компани Лтд. Оральная система доставки лекарственного препарата (варианты)
US7151400B2 (en) * 2004-07-13 2006-12-19 Taiwan Semiconductor Manufacturing Company, Ltd. Boost-biased level shifter
CN100370972C (zh) * 2006-01-10 2008-02-27 北京申科联华科技有限公司 一种具有益气养阴、活血复脉功效的片剂及制备方法
CN101808640A (zh) * 2007-08-02 2010-08-18 帝人制药株式会社 骨代谢异常所引起的疾病的预防药或治疗药
EP2242485A4 (en) * 2008-02-15 2013-05-08 Sun Pharma Advanced Res Co Ltd ORAL TABLET WITH CONTROLLED RELEASE
CN118370733B (zh) * 2024-06-21 2024-10-01 山东新时代药业有限公司 一种钙代谢调节药物氯膦酸二钠片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83421C (fi) † 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
AU664368B2 (en) * 1991-02-26 1995-11-16 Norwich Eaton Pharmaceuticals, Inc. Methods for the treatment of osteoporosis
SE501389C2 (sv) † 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss

Also Published As

Publication number Publication date
PL173026B1 (pl) 1998-01-30
HUT70214A (en) 1995-09-28
NO944405L (no) 1994-11-24
GR940300095T1 (en) 1995-01-31
FI945313A (fi) 1994-12-13
CN1095267A (zh) 1994-11-23
CZ10095A3 (en) 1995-10-18
NZ254765A (en) 1997-02-24
AU687744B2 (en) 1998-03-05
ATE128363T1 (de) 1995-10-15
WO1994026310A1 (de) 1994-11-24
CA2162470A1 (en) 1994-11-24
RU2134103C1 (ru) 1999-08-10
FI111519B (fi) 2003-08-15
EP0625355A1 (de) 1994-11-23
AU4702093A (en) 1994-12-12
DK0625355T5 (da) 2003-12-01
IL106743A0 (en) 1993-12-08
EP0625355B2 (de) 2003-06-25
NO307548B1 (no) 2000-04-25
HU220872B1 (en) 2002-06-29
HU9403160D0 (en) 1995-02-28
IL106743A (en) 1999-11-30
CN1041797C (zh) 1999-01-27
JPH08509697A (ja) 1996-10-15
DK0625355T3 (da) 1995-12-27
PL307133A1 (en) 1995-05-02
EP0697890A1 (de) 1996-02-28
US5650168A (en) 1997-07-22
ES2065313T3 (es) 1995-12-01
BR9307859A (pt) 1996-01-09
NO944405D0 (no) 1994-11-17
CA2162470C (en) 1998-06-16
SK4895A3 (en) 1997-01-08
JP3699110B2 (ja) 2005-09-28
CZ287984B6 (cs) 2001-03-14
TW350772B (en) 1999-01-21
DK0625355T4 (da) 2003-10-06
KR960702322A (ko) 1996-04-27
DE59300688D1 (de) 1995-11-02
KR100263284B1 (ko) 2000-08-01
SK281193B6 (sk) 2001-01-18
FI945313A0 (fi) 1994-11-11
ES2065313T1 (es) 1995-02-16
ES2065313T5 (es) 2004-01-01
EP0625355B1 (de) 1995-09-27
AT128U1 (de) 1995-03-27
GR3017547T3 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
UA39884C2 (uk) Таблетка на основі клодронової кислоти, спосіб її одержання та спосіб лікування остеопорозу
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
FR2526443B1 (fr) Activateur de plasminogene de tissu humain, son procede de production et composition pharmaceutique le contenant
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
NO905264D0 (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
WO2003011204A3 (en) Drug delivery systems
FI932761A0 (fi) Foerfarande foer framstaellning av aktiva substanser innehaollande mikropartiklar av hydrolytiskt nedbrytbara polymerer
MX9201782A (es) Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
ATE65505T1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
GEP20063773B (en) Steroid Sulphatase Inhibitors
ATE225647T1 (de) Dosierungsform zur verabreichung von flüssige arzneimittel formulierung
GR3018185T3 (en) Medicaments containing polyhydroxymethylene-derivatives, process for their manufacture and use thereof.
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
YU156788A (en) Process for producing matrix for releasing and/or dosing healing active material
ATE156350T1 (de) Peptidarzneistoffe enthaltende pellets und ihre herstellung sowie deren verwendung
DE3763851D1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
HU9303230D0 (en) Use of lanoline derivatives for promotion of transdermal resorption of drugs and other biological substances
ES2088956T3 (es) Estructura de tableta multifraccionable.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
HUT43793A (en) Process for production of medical and cosmetical compounds and their active substances
AU3445489A (en) Luminide and macroluminide class of pharmaceuticals
EP0305277A3 (fr) Application de l'amino-2 trifluoro-méthoxy-6 benzothiazole pour obtenir un médicament destiné au traitement des troubles du sommeil et de la dépression
FI860816A (fi) Menetelmä terapeuttisesti käyttökelpoisten polyprenyyliyhdisteiden valmistamiseksi
KR940006600A (ko) 혈전용해의 활성을 가지는 의약품의 제조를 위한 트롬빈의 직접적인 억제제의 이용
SE8902624D0 (sv) New pharmaceutical preparations